The US is using free trade agreements to address the global free rider problem in pharmaceutical R&D. This brief article outlines several objections to that approach.
Free Trade Against Free Riders?
Pharma Pricing & Reimbursement
Available at: https://scholarship.law.bu.edu/faculty_scholarship/1742